A detailed history of Chicago Partners Investment Group LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Chicago Partners Investment Group LLC holds 16,060 shares of BMY stock, worth $854,231. This represents 0.03% of its overall portfolio holdings.

Number of Shares
16,060
Previous 16,244 1.13%
Holding current value
$854,231
Previous $880,000 24.32%
% of portfolio
0.03%
Previous 0.04%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 31, 2024

SELL
$40.25 - $52.99 $7,406 - $9,750
-184 Reduced 1.13%
16,060 $666,000
Q1 2024

Apr 25, 2024

BUY
$47.98 - $54.4 $1,487 - $1,686
31 Added 0.19%
16,244 $880,000
Q4 2023

Feb 23, 2024

BUY
$48.48 - $57.85 $6,690 - $7,983
138 Added 0.86%
16,213 $831,000
Q3 2023

Oct 26, 2023

SELL
$57.89 - $64.73 $9,551 - $10,680
-165 Reduced 1.02%
16,075 $932,000
Q2 2023

Aug 07, 2023

BUY
$63.71 - $70.74 $331,865 - $368,484
5,209 Added 47.22%
16,240 $1.04 Million
Q1 2023

Apr 26, 2023

SELL
$65.71 - $74.53 $3,219 - $3,651
-49 Reduced 0.44%
11,031 $764,000
Q4 2022

Feb 09, 2023

SELL
$68.48 - $81.09 $294,943 - $349,254
-4,307 Reduced 27.99%
11,080 $797,000
Q3 2022

Nov 09, 2022

BUY
$0.13 - $76.84 $50 - $29,813
388 Added 2.59%
15,387 $1.22 Million
Q2 2022

Aug 04, 2022

SELL
$72.62 - $79.98 $167,534 - $184,513
-2,307 Reduced 13.33%
14,999 $1.11 Million
Q1 2022

May 20, 2022

BUY
$61.48 - $73.72 $647,937 - $776,935
10,539 Added 155.74%
17,306 $1.33 Million
Q4 2021

Feb 15, 2022

SELL
$53.63 - $62.52 $44,298 - $51,641
-826 Reduced 10.88%
6,767 $452,000
Q3 2021

Nov 12, 2021

SELL
$59.17 - $69.31 $50,827 - $59,537
-859 Reduced 10.16%
7,593 $449,000
Q2 2021

Aug 02, 2021

SELL
$61.91 - $67.42 $17,706 - $19,282
-286 Reduced 3.27%
8,452 $572,000
Q1 2021

Apr 28, 2021

BUY
$59.34 - $66.74 $35,069 - $39,443
591 Added 7.25%
8,738 $576,000
Q4 2020

Jan 27, 2021

SELL
$57.74 - $65.43 $75,119 - $85,124
-1,301 Reduced 13.77%
8,147 $526,000
Q3 2020

Nov 06, 2020

BUY
$57.43 - $63.64 $344 - $381
6 Added 0.06%
9,448 $579,000
Q2 2020

Jul 31, 2020

BUY
$54.82 - $64.09 $12,663 - $14,804
231 Added 2.51%
9,442 $548,000
Q1 2020

Apr 22, 2020

SELL
$46.4 - $67.43 $27,561 - $40,053
-594 Reduced 6.06%
9,211 $558,000
Q4 2019

Jan 24, 2020

BUY
$49.21 - $64.19 $176,565 - $230,313
3,588 Added 57.71%
9,805 $655,000
Q3 2019

Oct 31, 2019

BUY
$42.77 - $50.71 $24,849 - $29,462
581 Added 10.31%
6,217 $338,000
Q2 2019

Jul 24, 2019

BUY
$44.62 - $49.34 $15,884 - $17,565
356 Added 6.74%
5,636 $241,000
Q1 2019

Apr 22, 2019

SELL
$45.12 - $53.8 $306,951 - $366,001
-6,803 Reduced 56.3%
5,280 $240,000
Q4 2018

Jan 11, 2019

SELL
$48.76 - $63.23 $301,434 - $390,887
-6,182 Reduced 33.85%
12,083 $577,000
Q3 2018

Nov 05, 2018

BUY
$55.19 - $62.25 $314,969 - $355,260
5,707 Added 45.45%
18,265 $908,000
Q2 2018

Aug 31, 2018

BUY
$50.53 - $62.98 $399,187 - $497,542
7,900 Added 169.6%
12,558 $695,000
Q1 2018

Apr 27, 2018

SELL
$59.92 - $68.98 $17,197 - $19,797
-287 Reduced 5.8%
4,658 $0
Q4 2017

Mar 28, 2018

SELL
$59.94 - $65.35 $130,908 - $142,724
-2,184 Reduced 30.64%
4,945 $0
Q3 2017

Nov 22, 2017

BUY
$55.23 - $63.74 $393,734 - $454,402
7,129
7,129 $0

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $113B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Chicago Partners Investment Group LLC Portfolio

Follow Chicago Partners Investment Group LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Chicago Partners Investment Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Chicago Partners Investment Group LLC with notifications on news.